Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 4, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

August 31, 2026

Conditions
COPD
Interventions
DEVICE

TLD

Patients allocated to experimental group will receive TLD therapy during which radiofrequency energy will be delivered to vagus nerve surrounding airway under bronchoscopy.

OTHER

Sham TLD procedure

Patients allocated to control group will receive sham TLD procedure during which catheter will be placed in all treatment locations with no radiofrequency energy delivered.

OTHER

Standard of care

Patients will also receive standard of care that meet the recommendations of GOLD guideline.

Trial Locations (1)

610000

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

Hangzhou Broncus Medical Co., Ltd.

INDUSTRY

NCT05799664 - Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD | Biotech Hunter | Biotech Hunter